• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$4.50 $0.02 (0.45%)

REAL-TIME: Last trade at

Celldex Therapeutics, Inc.

NASDAQ:CLDX

Jump to this page for:

Related Resources

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2

5/25/2012 by Seeking Alpha

Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VO

5/24/2012 by Nasdaq

NetApp and American Capital Mortgage Investment Corporation Among Most Active Stocks in Pre-Market T

5/24/2012 by Minyanville

Finding a Pathway to Approval

5/24/2012 by DailyFinance

After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC

5/23/2012 by Nasdaq

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

5/18/2012 by 247wallst

NASDAQ Changes Up Biotech Index Members & Weightings

5/14/2012 by 247wallst

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY

5/10/2012 by 247wallst

Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost

3/23/2012 by DailyFinance

5 of Last Week's Biggest Losers

2/27/2012 by DailyFinance

How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch

2/24/2012 by Minyanville

8 Biotech Companies Rethinking Immunotherapy for Brain Tumors

2/22/2012 by Minyanville

The Stocks Wall Street Loves

9/9/2011 by DailyFinance

5 Oncology Drugs Available for Partnering

4/27/2011 by Seeking Alpha

Interview: ImmunoCellular Therapeutics' CEO on What's New in Cancer Therapy

4/5/2011 by Seeking Alpha

Major FDA Approval Could Pave the Way for These 5 Biotechs

3/31/2011 by Seeking Alpha

Ipilimumab Approval Highlights Active Immunotherapy Renaissance

3/27/2011 by Seeking Alpha

To Partner or Not to Partner: That is the Question

3/10/2011 by Seeking Alpha

Is Celldex Poised for a Comeback?

3/1/2011 by Seeking Alpha

Battered but Unbroken Biotechs

2/28/2011 by Seeking Alpha

Friday Options Brief: USO, MWW, AMCC & CLDX

1/28/2011 by Seeking Alpha

Celldex: Can Anything Halt Its Slide?

1/26/2011 by Seeking Alpha

Celldex: Can Anything Halt It's Slide?

1/26/2011 by Seeking Alpha

Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer

10/26/2010 by Seeking Alpha

CellDex Therapeutics Is Back on the Radar

10/6/2010 by Seeking Alpha

Lawyers vs. Celldex?

10/5/2010 by Fox Business

Closing Bell: Easing to the Rescue (CLDX, GYMB, WFR, TLB, WAG, SKS, HOG)

10/5/2010 by BloggingStocks

Attractive and Unattractive Small Cap Stocks

9/27/2010 by Seeking Alpha

Is Celldex Therapeutics on the Rebound?

9/14/2010 by Seeking Alpha

7 Oversold Stocks Seeing Recent Insider Buying

9/13/2010 by Seeking Alpha

Celldex Reeling From Pfizer Breakup

9/7/2010 by Seeking Alpha

CellDex Therapeutics Gets Hammered After Divorce With Pfizer, Time to Buy?

9/7/2010 by Seeking Alpha

Roche Plans Cutbacks on Pressure From Failures: Biotech's Latest Mishaps

9/5/2010 by Seeking Alpha

Cledex Slumps As Pfizer Pulls Out Of Drug-Development Deal

9/3/2010 by Smart Money

CORRECT: Celldex Slumps As Pfizer Pulls Out Of Drug-Development Deal

9/3/2010 by Smart Money

Stocks Gain for Fourth Day, Ending the Week Up

9/3/2010 by Seeking Alpha

Option Traders Buying TransDigm Calls and Avanir Pharmaceutical Puts

9/2/2010 by BloggingStocks

Competitive Technologies: Short Squeeze Coming or Another Leg Down?

8/25/2010 by Seeking Alpha